{"ticker": {"uuid": "fc539048-8962-4065-8c33-6ae9f4337d64", "symbol": "600572", "name": "Zhejiang CONBA Pharmaceutical Co.,Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Adneuris Therapeutics Grants Exclusive License to Zhejiang", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxPQVlGU3lFLU5Ca0IxNWlHZUZNdFVBSFRudVNabGlfTmNOdXFhNnN1OFVmd0ZaLWVsaWFfOVpYWHBuS0x5ejhYSldHNnFBRmg4UWFJTDNFUFhPTjZkTDJKY3dHa3RXUVhYSXdaRFVjcHZqVFRuYWJGSmhRQXlISHhnRFUxMGczeGdaYl9NNmZ4TVY3dkRpZEQwc3BMNnRNcnBWTDZseGpoTXpZWFNzalVlZ1dadlVhZHA2elNNbzJFZ25DUTgtb21YY1JoSk9reG9mZnBzTHNxRFBoc3Q5TmxHeEE3Slg1SzJsSzh2amJORzBEUy1KY1JwM2hnWkFRcEFkNDVYdWkzS2IwU19peHQtd1ZQaVhNandRY2xBQw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-07-14T12:30:00+00:00", "published_display": "14 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Adneuris Therapeutics Grants Exclusive License to Zhejiang", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxPQVlGU3lFLU5Ca0IxNWlHZUZNdFVBSFRudVNabGlfTmNOdXFhNnN1OFVmd0ZaLWVsaWFfOVpYWHBuS0x5ejhYSldHNnFBRmg4UWFJTDNFUFhPTjZkTDJKY3dHa3RXUVhYSXdaRFVjcHZqVFRuYWJGSmhRQXlISHhnRFUxMGczeGdaYl9NNmZ4TVY3dkRpZEQwc3BMNnRNcnBWTDZseGpoTXpZWFNzalVlZ1dadlVhZHA2elNNbzJFZ25DUTgtb21YY1JoSk9reG9mZnBzTHNxRFBoc3Q5TmxHeEE3Slg1SzJsSzh2amJORzBEUy1KY1JwM2hnWkFRcEFkNDVYdWkzS2IwU19peHQtd1ZQaVhNandRY2xBQw?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-07-14T12:30:00+00:00", "published_display": "14 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 42, "total_relevant": 1, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 1, "score": 50, "total": 1, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 72, "events": [{"event": "general", "label": "Market update", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 4.28, "latest_week": "2026-07-17", "one_week_move": 3.9, "four_week_move": 7.7, "twelve_week_move": -2.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.582507, "market_dynamics_buy_signal": false, "relative_strength": 1.182036, "fair_value_gap": -5.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.163, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.9% over one week, +7.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "GlobeNewswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "directly relevant article"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.9% over one week, +7.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Adneuris Therapeutics Grants Exclusive License to Zhejiang"}], "updated_at": "2026-07-24T15:45:49.650864+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}